0001293577-17-000001.txt : 20170123 0001293577-17-000001.hdr.sgml : 20170123 20170123153209 ACCESSION NUMBER: 0001293577-17-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170119 FILED AS OF DATE: 20170123 DATE AS OF CHANGE: 20170123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katz Richard D CENTRAL INDEX KEY: 0001293577 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 17540981 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-01-19 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001293577 Katz Richard D 4505 EMPEROR BOULEVARD SUITE 300 DURHAM NC 27703 0 1 0 0 VP & Chief Financial Officer Common Stock 2017-01-19 4 A 0 3958 0 A 3958 D Stock Option (right to buy) 4.85 2017-01-19 4 A 0 105000 0 A 2027-01-18 Common Stock 105000 105000 D This option was granted on January 19, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018. /s/ Lori R. Harrelson, attorney-in-fact 2017-01-23